Like many growing organisations, her group didn’t start with a tightly controlled set of partners. At one point, they were working with close to a 100 different labs across their network. Each relationship reflected a clinician’s preference, a local connection, or a routine built over time. Individually, those relationships worked. Collectively, they didn’t.
“We had to start narrowing it down,” Lohman says. “From a 100 to 25, and eventually, to 10.”
The goal wasn’t simply to reduce options but to build a system that balanced consistency with enough flexibility to earn clinician trust.
“There’s a difference between a vendor and a partner,” Lohman says. “A partner helps you deliver on your patient promise.”
That difference becomes most visible in the moments when practitioners are challenged most—complex cases, unexpected outcomes, situations where the “right” answer isn’t immediately obvious. In those cases, clinicians don’t just need a product. They need support. They need responsiveness. They need feedback that helps them adjust in real time. With the right lab relationships, Lohman found something shifted.
“I’ve taken on cases I wouldn’t have before,” she says. “Not because I changed, but because I had the support behind me.”
Across a multi-location organisation, those dynamics begin to scale. With fewer lab partners, expectations become clearer and feedback cycles tighten. Over time, what was once variable becomes more predictable in both performance and cost.
From a financial perspective, the impact of standardisation appears less as a single line item and more as a shift in the power of revenue operations across an entire network. Procurement becomes more efficient. Negotiation power increases. But the underlying driver remains the same: reducing variability so that each chair, each appointment, and each interaction operates as close to its potential as possible.
According to Gad Zuaretz, what changes when standards begin to hold is visibility. With consistent systems in place, operators can track performance at more a granular level—by location, by provider, even by case type—and identify where variation is creeping in. That visibility creates a feedback loop. Training improves. Workflows tighten. Over time, what was once unpredictable becomes measurable and then manageable.
“At the end of the day, it’s all about time,” Zuaretz explained. “If you can scan once instead of multiple times, if you reduce remakes, you’re not just improving quality; you’re giving that time back to the clinician.”
Making that shift still requires more than defining a preferred system. It depends on how those standards are introduced, how decisions are explained, and how trust is built over time. Clinicians need to understand not just what has been standardised, but why.
“Change is hard,” Lohman says. “But there’s a process you can use to help. Here’s the system. Here’s why we’ve created it. Here’s what challenge we think it will help you with.”
At scale, standardisation stops looking like control and starts functioning like leverage—turning consistency across individual practices into a collective advantage. For DSOs, the question is no longer whether to standardise. The benefits of that decision are clear.
The real question is whether those standards can hold across different teams, systems, and ways of working. The advantage of standardisation isn’t realised on whiteboards or in planning sessions. It’s realised when clinicians choose to use the partners and workflows in front of them without losing the judgement and adaptability that made those practices work in the first place.
As Russell puts it, “The DSO’s role is to serve offices by removing barriers, not imposing control.”